Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-020380

Chief Scientific Officer sold 2,591 shares at $8.06 ($20,883)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Or Yat Sun Chief Scientific Officer 2024-12-06 Sale 10b5-1 −2,591 $8.06 $20,883 369,109 D
Open-market sales · 2,591 sh · avg $8.06 · $20,883
Loading xslF345X05/form4.xml…